Trial Profile
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Dec 2021
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Cardiovascular disorders; Diabetes mellitus; Obesity
- Focus Pharmacodynamics
- 10 Oct 2017 Status changed from active, no longer recruiting to completed.
- 27 Oct 2015 Planned End Date changed from 1 Dec 2015 Jun 2008 to 1 Jun 2018 as reported by ClinicalTrials.gov.
- 24 Jul 2014 Planned End Date changed from 1 Jun 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.